Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Authors:

Abstract
Neurocognitive deficits are a common late effect found among long-term survivors of childhood acute lymphoblastic leukemia (ALL). Survivors of childhood ALL who receive chemotherapy without prophylactic cranial irradiation therapy are at risk for impairment in executive function and processing speed.1,2 Factors that increase this risk include being younger at treatment and having higher levels of exposure to high-dose intravenous methotrexate sodium and intrathecal methotrexate.1,2 Little is known about the specific sequence of cellular injury after chemotherapy, and accurate early identification of individual patients at greatest risk is still beyond current capabilities.

This publication has 22 references indexed in Scilit: